Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 3 min ago
Peer-reviewedCC BY-NC 4.0Haematologica

Lorlatinib-induced remission in refractory acute myeloid leukemia with an anaplastic lymphoma kinase fusion

  • Leora Boussi1
  • Natalia Tijaro Ovalle2
  • Brandon S. Imber3
  • Mark D. Ewalt4
  • Michael Glick5
  • Brian Shaffer2
  • Eytan M. Stein1
5 affiliations
  1. 1Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
  2. 2Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
  3. 3Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center
  4. 4Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center
  5. 5Division of Gastroenterology and Hepatology, New York University Langone Health System, New York, NY, USA
Read full textPDFDOICite

Related

  1. Complete remission with single agent lorlatinib in children with ALK+ anaplastic large cell lymphoma and central nervous system involvement: a case report
    Crystal Wang, Yael Mossé, Lianna J. Marks +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  2. Therapy-related T-lymphoblastic lymphoma following acute myeloid leukemia remission with IDH2 mutation persistence
    Jonathan J. Cho, Huan-You Wang, Grace Y. Lin +1
    Leukemia Research ReportsPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  3. Addition of thiotepa to total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute leukemia and lymphoma: a propensity score-matched retrospective study.
    Minglu Li, Shuqin Zhang, Xiaoyong Man +4
    Annals of hematologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCDOAJ
  4. SAFETY AND ANTITUMOR ACTIVITY OF NEMTABRUTINIB PLUS VENETOCLAX IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA: PART 1 OF THE PHASE 3 BELLWAVE-010 STUDY
    Paolo GHIA, Mauricio CHANDIA CABAS, Vernon Johan LOUW +13
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textHuman geneticsDOAJ
  5. Bilateral breast implant-associated anaplastic large cell lymphoma presenting as late peri-implant effusion: a case report
    Journal of surgical case reportsPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC

Cite

BibTeXRIS
BibTeX
@article{boussi2026lorlatinibinduced,
  title = {{Lorlatinib-induced remission in refractory acute myeloid leukemia with an anaplastic lymphoma kinase fusion}},
  author = {Leora Boussi and Natalia Tijaro Ovalle and Brandon S. Imber and Mark D. Ewalt and Michael Glick and Brian Shaffer and Eytan M. Stein},
  journal = {Haematologica},
  year = {2026},
  month = may,
  doi = {10.3324/haematol.2026.300893},
  url = {https://doi.org/10.3324/haematol.2026.300893},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Lorlatinib-induced remission in refractory acute myeloid leukemia with an anaplastic lymphoma kinase fusion
AU  - Leora Boussi
AU  - Natalia Tijaro Ovalle
AU  - Brandon S. Imber
AU  - Mark D. Ewalt
AU  - Michael Glick
AU  - Brian Shaffer
AU  - Eytan M. Stein
PY  - 2026
DA  - 2026/05/28
JO  - Haematologica
DO  - 10.3324/haematol.2026.300893
UR  - https://doi.org/10.3324/haematol.2026.300893
SN  - 0390-6078
SN  - 1592-8721
ER  -